XERNA
Live / Registered — Registered (as of 29 Jul 2025)
What this means for you
Registered since 29 Jul 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Jul 2031: the §8 declaration of use).
Record
- Serial number
- 90635722
- Registration number
- 7874011
- Mark type
- Word mark
- Filed
- 09 Apr 2021
- Published for opposition
- 18 Jan 2022
- Registered
- 29 Jul 2025
- Next maintenance filing
- §8 declaration of use, due by 29 Jul 2031 (grace period to 29 Jan 2032)
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals
Owner
- OncXerna Therapeutics, Inc., Waltham, MA, US
- OncXerna Therapeutics, Inc., Waltham, MA, US
- OncXerna Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 29 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2025 — USE AMENDMENT FILED
- 13 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2024 — SOU EXTENSION 5 GRANTED
- 14 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2024 — SOU EXTENSION 4 GRANTED
- 13 Mar 2024 — SOU EXTENSION 4 FILED
- 13 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED